MAP2K1 and infection: Treatment with 50–100 mg/kg baicalin also upregulated abnormal RAS protein expression and attenuated the p-MEK1/2/MEK1/2 and p-ERK1/2/ERK1/2 ratios compared to those in the infection group (P < 0.05; Figure 10).